Status:
UNKNOWN
Evaluation of PET CT in the Management of Patients With Crohn's Disease.
Lead Sponsor:
Rabin Medical Center
Conditions:
Crohn's Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
18F-FDG PET/CT (2-\[fluorine-18\] fluoro-2-deoxy-D-glucose, Positron emission tomography- CT) is a noninvasive technique that allows quantifying and precisely localizing 18F-FDG uptake in the entire b...
Eligibility Criteria
Inclusion
- Patients suspicious for active disease:
- Patients with suspected but undiagnosed Crohn's disease
- Patients with serological markers of inflammation (elevated ESR, CRP or thrombocytosis) but clinically in remission
- Patients with a stricture which might be fibrous in which case surgery is indicated or inflammatory for which medical management is indicated
- Able to sign a consent form
Exclusion
- Pregnancy
- Breastfeeding
- Infectious colitis determined at the initial checkup
- Allergy to iodine contrast
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00731809
Start Date
April 1 2008
End Date
October 1 2010
Last Update
December 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center
Petah Tikva, Israel, 49100